Use of oral antidiabetic drugs in the treatment of maturity-onset diabetes of the young: A mini review

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F18%3A43915114" target="_blank" >RIV/00216208:11120/18:43915114 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11130/18:10371453 RIV/00064173:_____/18:N0000022 RIV/00064203:_____/18:10371453

Result on the web

<a href="https://doi.org/10.1002/dmrr.2940" target="_blank" >https://doi.org/10.1002/dmrr.2940</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1002/dmrr.2940" target="_blank" >10.1002/dmrr.2940</a>

Result language

angličtina

Original language name

Use of oral antidiabetic drugs in the treatment of maturity-onset diabetes of the young: A mini review

Original language description

Background: MODY (Maturity-onset diabetes of the young) is a genetically linked group of clinically heterogeneous subtypes of diabetes. Roughly 5% of people with diabetes mellitus diagnosed prior to age 45 have MODY diabetes, the majority of whom have been erroneously diagnosed as patients with either Type 1 or Type 2 diabetes and, as a result, have been improperly treated. Genetic identification of MODY diabetes and its subtypes allows proper treatment and enables clinicians to switch many patients to oral antidiabetic agents, mainly sulphonylureas. However, some new classes of oral diabetic drugs have also been tested and found to be effective in MODY patients. Methods: We have searched for research articles and case reports written in full-text English or with an English abstract, using the following keywords: MODY and oral antidiabetic* in the databases Cohrane Library, PubMed and Science Direct. Results: Therapeutic options using currently standardized oral antidiabetic drugs (mainly sulphonylureas), as well as more experimental treatment with other classes of oral antidiabetic drugs in different types of MODY are discussed, with special focus on the therapy of the most common MODY subtypes, including specific conditions as pregnancy. Conclusion: This review article summarizes the currently available information about oral antidiabetic treatment available for patients with MODY diabetes.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30202 - Endocrinology and metabolism (including diabetes, hormones)

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2018

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Diabetes/Metabolism Research and Reviews

ISSN

1520-7560

e-ISSN

—

Volume of the periodical

34

Issue of the periodical within the volume

1

Country of publishing house

GB - UNITED KINGDOM

Number of pages

6

Pages from-to

"Article e2940"

UT code for WoS article

000422967700004

EID of the result in the Scopus database

2-s2.0-85030645323